Skip to main content
TipRanks
Go Ultimate75% OFF

GC Biopharma Corp. (006280) Stock Statistics & Valuation Metrics

Total Valuation

GC Biopharma Corp. has a market cap or net worth of KRW 1.51T. The enterprise value is KRW 2.17T.

Market Cap
KRW 1.51T
Enterprise Value
KRW 2.17T

Share Statistics

GC Biopharma Corp. has 11,686,538 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
11,686,538
Owned by Insiders
―
Owned by Institutions
5.74%

Financial Efficiency

GC Biopharma Corp.’s return on equity (ROE) is -0.00 and return on invested capital (ROIC) is 2.33%.

Return on Equity (ROE)
-0.00
Return on Assets (ROA)
-0.00
Return on Invested Capital (ROIC)
2.33%
Return on Capital Employed (ROCE)
0.04
Revenue Per Employee
846.99M
Profits Per Employee
-1.99M
Employee Count
2,351
Asset Turnover
0.67
Inventory Turnover
1.63

Valuation Ratios

The current PE Ratio of GC Biopharma Corp. is 9.98. GC Biopharma Corp.’s PEG ratio is -0.06.

PE Ratio
9.98
PS Ratio
0.80
PB Ratio
1.17
Price to FCF
20.77
Price to Operating Cash Flow
7.87
PEG Ratio
-0.06

Income Statement

In the last 12 months, GC Biopharma Corp. had revenue of 1.99T and earned -4.67B in profits. Earnings per share was -409.51.

Revenue
1.99T
Gross Profit
536.00B
Operating Income
67.81B
Pretax Income
-35.33B
Net Income
-4.67B
EBITDA
155.46B
Earnings Per Share (EPS)
-409.51

Cash Flow

In the last 12 months, operating cash flow was 184.28B and capital expenditures -111.65B, giving a free cash flow of 72.64B billion.

Operating Cash Flow
184.28B
Free Cash Flow
72.64B
Free Cash Flow per Share
6623.85

Dividends & Yields

GC Biopharma Corp. pays an annual dividend of ―, resulting in a dividend yield of 1.14%

Dividend Per Share
―
Dividend Yield
1.14%
Payout Ratio
N/A
Free Cash Flow Yield
4.82%
Earnings Yield
9.86%

Stock Price Statistics

Beta
0.10
52-Week Price Change
-0.30%
50-Day Moving Average
129628.00
200-Day Moving Average
134986.58
Relative Strength Index (RSI)
47.78
Average Volume (3m)
24.08K

Important Dates

GC Biopharma Corp. upcoming earnings date is Mar 23, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 16, 2026
Next Earnings Date
Mar 23, 2027
Ex-Dividend Date
―

Financial Position

GC Biopharma Corp. as a current ratio of 1.20, with Debt / Equity ratio of 80.67%

Current Ratio
1.20
Quick Ratio
0.42
Debt to Market Cap
0.48
Net Debt to EBITDA
6.00
Interest Coverage Ratio
1.35

Taxes

In the past 12 months, GC Biopharma Corp. has paid -5.65B in taxes.

Income Tax
-5.65B
Effective Tax Rate
0.16

Enterprise Valuation

GC Biopharma Corp. EV to EBITDA ratio is 18.30, with an EV/FCF ratio of 33.09.

EV to Sales
1.28
EV to EBITDA
18.30
EV to Free Cash Flow
33.09
EV to Operating Cash Flow
13.04

Balance Sheet

GC Biopharma Corp. has KRW 44.66B in cash and marketable securities with KRW 938.85B in debt, giving a net cash position of -KRW 894.19B billion.

Cash & Marketable Securities
KRW 44.66B
Total Debt
KRW 938.85B
Net Cash
-KRW 894.19B
Net Cash Per Share
-KRW 76.51K
Tangible Book Value Per Share
KRW 87.14K

Margins

Gross margin is 18.65%, with operating margin of 3.57%, and net profit margin of 7.60%.

Gross Margin
18.65%
Operating Margin
3.57%
Pretax Margin
10.19%
Net Profit Margin
7.60%
EBITDA Margin
7.00%
EBIT Margin
3.57%

Analyst Forecast

The average price target for GC Biopharma Corp. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
-2.99%
EPS Growth Forecast
177.51%

Scores

Smart Score
―
AI Score
54